Recent Closure With Aspen Clinical Research shutting down in late 2024, there is a potential opportunity to engage with former clients or partners who may be seeking alternative clinical research services or facilities for their ongoing or upcoming trials.

Market Gap As a mid-sized clinical research facility with specialized in-patient services, Aspen closed, leaving a gap in Utah and similar regional markets that larger CROs may want to fill with their flexible and comprehensive trial solutions.

Client Support Needs Clients who previously relied on Aspen for Phase II-IV clinical pharmacology studies may require new partners with the capacity and expertise to support complex therapeutic areas and all trial phases, presenting opportunities for providers with advanced offerings.

Growth Segment Given the competitive landscape where large CROs dominate, targeting smaller and mid-sized research centers that are closing or consolidating presents a strategic entry point for expanding reach into niche or regional clinical trial markets.

Data & Infrastructure The halted operations of companies like Aspen highlight the importance of showcasing robust technological infrastructure and adaptable trial services to attract clients seeking reliability and innovation in clinical research engagement.